Furthermore, AKAP8L exhibited a strong predictive value for the identification of testicular germ cell tumors (TGCT), liver hepatocellular carcinoma (LIHC), rectum adenocarcinoma (READ) and colon adenocarcinoma (COAD), and has significant correlation with the total survival rate (OS), disease-specific survival rate (DSS) and progression-free interval (PFI) of COAD, kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), as well as prostate adenocarcinoma (PRAD). Here, AKAP8L is linked to prostate adenocarcinoma.